Welcome
Support Centre
25 July 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effects of a psychotherapy intervention in depressed patients with coronary artery disease
ISRCTN ISRCTN76240576
ClinicalTrials.gov identifier
Public title Effects of a psychotherapy intervention in depressed patients with coronary artery disease
Scientific title A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease - a randomised controlled trial (SPIRR-CAD)
Acronym SPIRR-CAD
Serial number at source ZKSK-371
Study hypothesis To determine the effects of a psychotherapy intervention on symptoms of depression in depressed patients with coronary artery disease
Ethics approval Ethics Committee, University of Göttingen. Date of approval: 25 October 2007 (ref: 5/10/07)
Study design Randomised, controlled, multi-centre clinical trial with masked evaluation (observer)
Countries of recruitment Germany
Disease/condition/study domain Depressive symptoms in patients with coronary artery disease
Participants - inclusion criteria 1. Gender: both
2. Minimum age: 18, maximum age: 75
3. Patients hospitalised for any manifestation of coronary heart disease with recent (<3 months old) coronary angiograms and elevated questionnaire scores for depression (Hospital Anxiety and Depression Scale [HADS] depression subscale >=8)
Participants - exclusion criteria 1. Severe heart failure or other acutely life-threatening conditions
2. Severe chronic inflammatory disease
3. Current suicidal tendency
4. Severe depressive episode or other severe mental illness
Anticipated start date 01/10/2008
Anticipated end date 30/09/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 569
Interventions Experimental intervention: Stepwise, manualised individual and group psychotherapy in addition to usual cardiological care. Patients randomised in the intervention group receive 3 sessions of individual psychotherapy (50 minutes per session, 1 session per week). Only those patients with persisting symptoms of depression receive additional 25 sessions of group psychotherapy (90 minutes per session) over 10 months (first 20 sessions on a weekly basis, then 5 sessions once a month).

Control intervention: Usual cardiological care including one psychosocial information session
Primary outcome measure(s) Changes from baseline to year 1 in depressive symptoms (HADS-D)
Secondary outcome measure(s) The following will be monitored up to 24 months:
1. Remission of depressive disorder (Structured Clinical Interview [SCID]) at baseline and 12 months
2. Type D pattern, assessed by a self rating questionnaire (DS-14) at baseline, 1, 6, 12, and 24 months
3. Health-related quality of life, evaluated by the self rating questionnaires the 36-item Short Form health survey (SF-36) and EuroQuol-5D at baseline, 6, 12, and 24 months
4. Cardiovascular risk profile
5. Neuroendocrine and immunological activation
6. Coagulation
7. Heart rate variability
8. Cardiac events
9. Health care utilisation and costs
Sources of funding German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) (Germany)
Trial website
Publications
Contact name Prof  Christoph  Herrmann-Lingen
  Address University of Göttingen
Department of Psychosomatic Medicine and Psychotherapy
von-Siebold-Str. 5
  City/town Göttingen
  Zip/Postcode D-37075
  Country Germany
  Tel +49 551 39 67 07
  Fax +49 551 39 19150
  Email cherrma@gwdg.de
Sponsor University of Göttingen (Germany)
  Address c/o Prof. Dr. Christoph Herrmann-Lingen
Department of Psychosomatic Medicine and Psychotherapy
von-Siebold-Str. 5
  City/town Göttingen
  Zip/Postcode D-37075
  Country Germany
  Tel +49 551 39 67 07
  Fax +49 551 39 19150
  Email cherrma@gwdg.de
  Sponsor website: http://www.med.uni-goettingen.de
Date applied 26/02/2008
Last edited 01/04/2008
Date ISRCTN assigned 27/03/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central